OncoSec Medical Incorporated logo (PRNewsfoto/OncoSec Medical Incorporated)


OncoSec Medical Incorporated, a biotechnology company, focuses on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target and attack cancer. Its lead product candidate is ImmunoPulse IL-12 that uses electroporation device to deliver a DNA-encoded interleukin-12 for reversing the immunosuppressive microenvironment in the treated tumor.

OncoSec Medical - Trickle Research Q&A

Rocky Mountain Microcap Conference VI  - Denver 11.20.20